In ccRCC, a recurring alteration of the von Hippel–Lindau (VHL) gene has been described as leading to angiogenesis through the transcription of genes managed by hypoxia-inducible factor (HIF) like VEGF [14,15,16]. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.